Training of the IRCE pharmacy team to utilize the laminar flow-hood for the TICO (Therapeutics for In-patient Treatment with COVID-19) study

 

TICO (Therapeutics for In-patient Treatment with COVID-19) study is a newly awarded grant by the National Institute of Allergy & Infectious Diseases to IRCE/IHVN. It is a clinical trial evaluating different treatments that may improve the recovery of patients suffering from COVID-19 disease. Dr. Nnakelu Eriobu, the Country Director of the TICO study conducted a training for the IRCE pharmacy team to utilize the laminar flow-hood to constitute study drugs for the TICO study.



Leave a Reply